Cardiff Oncology Inc (CRDF)

2.640 -0.050 (-1.86%)
Closed USD Disclaimer

Cardiff Oncology Inc Company Profile

Industry
Biotechnology
Sector
Healthcare
Employees
-
Equity Type
ORD
Cardiff Oncology Inc. is a clinical-stage biotechnology company. The Company is focused on developing treatment for cancer patients. Its drug candidate onvansertib, is a polo-like kinase 1 (PLK1) adenosine triphosphate (ATP) competitive inhibitor with the combination of chemotherapy and targeted therapeutics. Its clinical trial includes TROV-054, CRDF-001 and TROV-053. TROV-054 is a Phase I b/2 open-label clinical trial of onvansertib in combination with FOLFIRI (folinic acid, fluorouracil, and irinotecan) and Avastin (bevacizumab). TROV-053 is a Phase II open-label clinical trial of onvansertib in combination with Zytiga (abiraterone acetate)/prednisone. CRDF-001 is a Phase 2 open-label multi-center clinical trial of onvansertib in combination with nanoliposomal irinotecan, leucovorin, and fluorouracil for second line treatment of patients with metastatic pancreatic ductal adenocarcinoma (mPDAC).
Contact Information
Address
San Diego,92121 United States
Phone
858 952 7570
Fax
-
Top Executives
Name
Age
Since
Title
Sandra L. Silberman 65 2017 Member of Clinical Advisory Board
Filip Janku 47 0000 Member of Clinical Advisory Board
Emmanuel Antonarakis 0 2020 Member of Clinical Advisory Board
Mark Erlander 61 2013 CEO & Director
Rodney S. Markin 64 2014 Independent Chairman of the Board
Gary W. Pace 73 2020 Independent Director
Renee P. Tannenbaum 70 2021 Independent Director
Lale White 66 2020 Independent Director
Carlo Maria Croce 0 0000 Member of Scientific Advisory Board
Paul R. Billings 70 2012 Member of Scientific Advisory Board
Charles R. Cantor 79 0000 Member of Scientific Advisory Board
Michael B. Yaffe 0 2018 Member of Clinical Advisory Board
Glenn J. Bubley 0 2018 Member of Clinical Advisory Board
Heinz-Josef Lenz 62 2020 Member of Clinical Advisory Board
Alberto Bardelli 0 2014 Member of Scientific Advisory Board
Brunangelo Falini 0 2010 Member of Scientific Advisory Board
K. Peter Hirth 70 2014 Member of Scientific Advisory Board
James O. Armitage 75 2020 Independent Director
Mani Mohindru 50 2021 Independent Director
Amer Zeidan 0 2020 Member of Clinical Advisory Board
Riccardo Dalla-Favera 70 2010 Member of Scientific Advisory Board
David Einstein 0 2018 Member of Clinical Advisory Board
Clear All
0Selected
Please try another search

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.